I am a Senior Medical Lead in the focus area of Cardiovascular, Renal and Metabolism (CVRM) at AstraZeneca. In short, I work to get our new diabetes treatments approved worldwide. This involves, among other things, conducting clinical trials, presenting data for medical authorities and publishing trial results in various medical journals.


I started at AstraZeneca's R&D site in Lund at the end of 2009 as a Global Safety Physician. When the site in Lund was closed and certain operations were relocated to AstraZeneca in Gothenburg, I chose to also move to be able to continue my work. 


I very much like my work, so we decided to move the whole family to Gothenburg. For me, it was an opportunity to extend my work in a field I am really passionate about; Cardiovascular, Renal and Metabolism (CVRM).

Ella Ekholm Senior Medical Lead, Late-stage Development, CVRM, BioPharmaceuticals R&D

Within BioPharmaceuticals R&D, medicines are developed from idea to market approval. After three years in AstraZeneca´s Patient Safety department, I began working as a study physician, and later became Senior Medical Lead.

I am a double specialist in internal medicine and endocrinology, and came to AstraZeneca from Malmö University Hospital, where I conducted clinical work within internal medicine and endocrinology. I received my Ph.D. for preclinical diabetes research from Uppsala University, and I am an Associate Professor in endocrinology at Lund University. I also hold a degree in Pharmaceutical Medicine (ECPM) from the University of Basel. 


I really enjoy the diversity in my work here. If you are interested in diabetes research, BioPharmaceuticals R&D is one of the most interesting places to be right now.

Ella Ekholm Senior Medical Lead, Late-stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D